4-Octyl itaconate suppresses IFN-γ–induced MHC II expression in bone marrow–derived macrophages
The Journal of Immunology · 01.10.2026 · 215 (10)
DOI: 10.1093/jimmun/vkag255 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 06.10.2026. Verfasst von Zhiying Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Succinates, Interferon-gamma, Macrophages, Histocompatibility Antigens Class II. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Zhejiang Science and Technology Department.
Abstract (Originalsprache)
Macrophages function as professional antigen-presenting cells that integrate inflammatory signals with metabolic reprogramming to shape immune responses. Itaconate, an immunometabolite derived from ACOD1/IRG1 activity in activated macrophages, has been implicated in the regulation of inflammatory responses, yet its role in interferon γ (IFN-γ)–driven antigen presentation programs remains incompletely understood. Here, we demonstrate that the itaconate derivative 4-octyl itaconate (4-OI) suppresses IFN-γ–induced antigen presentation programs in bone marrow-derived macrophages. 4-OI reduced surface major histocompatibility complex class II (MHC II) expression and downregulated key components of the antigen presentation machinery, including CIITA, H2-Ab1, and H2-Eb1. Transcriptomic analysis revealed broad suppression of IFN-γ–responsive immune pathways, particularly those associated with antigen processing and inflammatory signaling. Mechanistically, 4-OI attenuated IFN-γ–induced phosphorylation of JAK1, JAK2, and STAT1, and pharmacological inhibition of JAK signaling phenocopied its effects on MHC II expression, implicating involvement of the IFN-γ–JAK–STAT1–CIITA axis. In vivo, 4-OI similarly reduced IFN-γ–induced MHC II expression in splenic macrophages, accompanied by decreased PD-L1 expression as a parallel marker of macrophage activation. Together, these findings identify 4-OI as an immunometabolic regulator of IFN-γ–driven macrophage activation, associated with modulation of the JAK–STAT1–CIITA signaling axis and suppression of antigen presentation programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China.
- Department of Second Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang, China.
- Zhejiang Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang Province, Zhejiang Hospital, Hangzhou, China.
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang Science and Technology Department
Zitieren
APA
Zhou, Z., Ni, Y., Huang, S., Lin, Y., Yang, M., Wu, Y., Cai, G., & Yang, Z. (2026). 4-Octyl itaconate suppresses IFN-γ–induced MHC II expression in bone marrow–derived macrophages. The Journal of Immunology, 215(10). https://doi.org/10.1093/jimmun/vkag255
Vancouver
Zhou Z, Ni Y, Huang S, Lin Y, Yang M, Wu Y, et al. 4-Octyl itaconate suppresses IFN-γ–induced MHC II expression in bone marrow–derived macrophages. The Journal of Immunology. 2026;215(10). doi:10.1093/jimmun/vkag255
BibTeX
@article{Zhou2026,
author = {Zhou, Zhiying and Ni, Yixiu and Huang, Shanshan and Lin, Yijia and Yang, Mingkun and Wu, Yingwei and Cai, Guolong and Yang, Zhouxin},
title = {4-Octyl itaconate suppresses IFN-γ–induced MHC II expression in bone marrow–derived macrophages},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {10},
doi = {10.1093/jimmun/vkag255}
}
EUVIMED